New Approaches for NASH and NAFLD

Content Type: presentation

Presenter: Arun J. Sanyal, MBBS, MD

Presenter Credentials: Charles Caravati Professor of Medicine (and Former Chair), Division of Gastroenterology, Hepatology and Nutrition; Executive Director, Education Core, CCTR, Virginia Commonwealth University and VCU Director of Education Core- Clinical Center of Translational Research (CCTR), Virginia Commonwealth University, Richmond, VA

Presenter Disclosure: Advisory Committee/Board Member: Genentech, Genfit Consultant: Abbott, Amylin, Astellas, Bayer-Onyx, Exhalenz, Genfit, Gilead, Gore, Ikaria, Immuron, Merck, Norgine, Pfizer, Salix, Sanofi/Aventis, Takeda, Vertex Grant/Research Support: Genfit, Gilead, Intercept, Mochida, Roche, Salix, Sanofi/Aventis Royalties: UpToDate

Event: 2015 ACG Postgraduate Course

Release Date: 12/16/2015

Expiration Date: 12/16/2018

Objective: Outline the current management of NASH and NAFLD.